Author:
Deboever Nathaniel,Correa Arlene M.,Feldman Hope,Eisenberg Michael,Antonoff Mara B.,Mehran Reza J.,Rajaram Ravi,Rice David C.,Roth Jack A.,Sepesi Boris,Swisher Stephen G.,Vaporciyan Ara A.,Walsh Garrett L.,Hofstetter Wayne L.
Abstract
Objectives:
Our objective was to investigate overall survival (OS) and length of stay (LOS) associated with differing management for high output (>1 liter over 24 h) leaks (HOCL) following cancer related esophagectomy.
Summary Background:
Although infrequent, chyle leak following esophagectomy is an event that can lead to significant perioperative sequelae. Low volume leaks appear to respond to non-operative measures, while HOCL often require invasive therapeutic interventions.
Methods:
From a prospective single-institution database, we retrospectively reviewed patients treated from 2001-2021 who underwent esophagectomy for esophageal cancer. Within that cohort, we focused on a subgroup of patients who manifested a HOCL postoperatively. Clinicopathologic and operative characteristics were collected, including hospital length of stay and survival data.
Results:
A total of 53/2299 patients manifested a HOCL. These were mostly males (77%), with a mean age of 62 years. Of this group, 15 patients received non-operative management, 15 patients received prompt (<72 h from diagnosis) interventional management, and 23 received late interventional management. Patients in the late intervention group had longer length of stay compared to early intervention (Slope=9.849, 95% Confidence Interval [CI] 3.431 to 16.267). Late intervention (Hazard Ratio (HR) 4.772, CI: 1.384 to 16.460) and non-operative management (HR 4.731, CI: 1.294 to 17.305) were associated with increased mortality compared to early intervention. Patients with early intervention for HOCL had an overall survival similar to patients without chyle leaks in survival analysis.
Conclusions:
Patients with HOCL should receive early intervention in order to possibly reverse the prognostic implications of this potentially detrimental complication.
Publisher
Ovid Technologies (Wolters Kluwer Health)